Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03507452
Title First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer

ovary serous adenocarcinoma

malignant epithelial mesothelioma

pancreatic adenocarcinoma



Age Groups: senior adult

No variant requirements are available.